11
Collaborative Clinical Medicines Procurement Procurement & Distribution Interest Group Autumn Symposium: 11 th November 2010 Dr Anthony Grosso Formulary & Medicines Management Pharmacist [email protected]

Collaborative Clinical Medicines Procurement

Embed Size (px)

DESCRIPTION

Collaborative Clinical Medicines Procurement. Procurement & Distribution Interest Group Autumn Symposium: 11 th November 2010 Dr Anthony Grosso Formulary & Medicines Management Pharmacist [email protected]. Outline. Getting value for money: Outline. The past… The present… - PowerPoint PPT Presentation

Citation preview

Page 1: Collaborative Clinical Medicines Procurement

Collaborative Clinical Medicines Procurement Procurement & Distribution Interest Group

Autumn Symposium: 11th November 2010

Dr Anthony GrossoFormulary & Medicines Management Pharmacist

[email protected]

Page 2: Collaborative Clinical Medicines Procurement

Outline

Page 3: Collaborative Clinical Medicines Procurement

1. The past…

2. The present…

3. The future…

4. Key messages

Getting value for money: OutlineGetting value for money: Outline

Page 4: Collaborative Clinical Medicines Procurement

The past: NHS Procurement- ProactiveProactive

- ProgressiveProgressive

- Savings ++Savings ++

- Particularly effective for generic medicinesParticularly effective for generic medicines

Page 5: Collaborative Clinical Medicines Procurement

The past…NHS Clinical- Passive & reactive initially

- Through collaboration: increased activity

- Statin project: key milestone

Page 6: Collaborative Clinical Medicines Procurement

Medicine savings pathway: example- Opportunity identified by procurement: PREDICTED price drop- Opportunity assessed by clinical- Jointly scoped estimated savings per scenario- Stakeholder consultation- Modifications- Barriers identified - Clinical evaluation- Implementation- Marketing & counter-marketing strategy employed- Tracking & continual management

Page 7: Collaborative Clinical Medicines Procurement

The present…

- Active collaboration between procurement & clinical

- Opportunities identified by procurement – feasibility-tested and implementation led by clinical

- Opportunities identified by clinical - forensic examination of individual drug use and discrete therapeutic pathways

Page 8: Collaborative Clinical Medicines Procurement

Targets & Implementation- Allows for generation of multiple targets & savings ++

- Rank by level of saving vs. degree of effort

- Austerity – aids implementation!

- Proven track record e.g. Statins, ARBs, anti-TNFs, Growth Hormones, 5-ASAs, GCSFs, 5-HT3s etc…

Page 9: Collaborative Clinical Medicines Procurement

The Future

- Increased clinical input into procurement groups

- Further adaptation required 2013 + (White paper, PPRS, VBP, NICE/NPC)

Page 10: Collaborative Clinical Medicines Procurement

Key messages: NHS- Clinical + procurement specialists: collaborate more closely to generate greater opportunities for saving money

- Innovate: look beyond price differences e.g. homecare savings

- Designate more time & resource to implementation activities

- Share ideas among colleagues

Page 11: Collaborative Clinical Medicines Procurement

Key messages: Pharma- Threats & opportunities

- Must adapt accordingly

- Collaborate with clinical-procurement groups

- Develop innovative ideas that are mutually beneficial

- Motivate decision-makers and influencers WITHIN the NHS to actively market your product for you!